Proactive Investors - Run By Investors For Investors

Tilray inks medical marijuana supply deal with division of Big Pharma giant Novartis

The Canadian cannabis company will team up with Sandoz to develop non-smokable products for the medical marijuana market
Marijuana leaf in a clay dish held in white gloved hand
Tilray CEO Brendan Kennedy hopes Sandoz’s logo will give added credibility to its products

Tilray Inc (NASDAQ:TLRY) announced Tuesday it will be partnering with Swiss pharmaceutical giant Novartis AG, inking a supply and distribution agreement for medical marijuana.

Shares of the British Columbia-based cannabis company surged more than 7% to US$70.75 in Tuesday pre-market trading.

The cannabis company turned its existing partnership with Sandoz Canada Inc into an agreement with parent company Sandoz AG, a division of Novartis.

Tilray and Sandoz will collaborate on non-smokable products, including some co-branded cannabis products.

“It just made sense for us to reach an agreement with a company like Sandoz, which is known for its focus on patients, its reliable supply chain, a well-established sales force and a global distribution network,” said Tilray CEO Brendan Kennedy in a phone interview with Bloomberg.

Kennedy noted that a product with the Sandoz logo on it lends credibility to Tilray’s product.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

muffins and cannabis
November 29 2018
Dehydratech is essentially a delivery system that allows drugs and vitamins to get into the bloodstream quicker, while making them taste and smell better at the same time
October 30 2018
The firm wants to become the first publicly listed, globally focused, pure cannabis company
cannabis plant
December 14 2018
The Vancouver-based cannabis group services medical and recreational cannabis markets in Canada and internationally
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use